Moving in silico screening into practice: A minimalist approach to guide permeability screening!!

Letters in Drug Design and Discovery

Volumn 3, Issue 8, 2006, Pages 575-581

  Stoner, Chad L ^a   Troutman, Mathew ^a   Gao, Hua ^a   Johnson, Kjell ^a   Stankovic, Charles ^a   Brodfuehrer, Joanne ^a   Gifford, Eric ^a   Chang, Man ^a  

^a PFIZER INC   (United States)

Author keywords

ADME; Caco 2; Computational; In silico; MDCK; Pampa; Permeability

Indexed keywords

AREA UNDER THE CURVE; ARTICLE; ARTIFICIAL MEMBRANE; CELL STRAIN; COMPUTER MODEL; CONTROLLED STUDY; COST CONTROL; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG METABOLISM; DRUG PENETRATION; DRUG RESEARCH; DRUG SCREENING; HUMAN; HUMAN CELL; MEDICAL PRACTICE; MEMBRANE PERMEABILITY; PRIORITY JOURNAL; PROBABILITY; VALIDATION PROCESS;

EID: 33749596971     PISSN: 15701808     EISSN: None     Source Type: Journal    
DOI: 10.2174/157018006778194736     Document Type: Article

References (25)

1. Angell, M. The Truth about Drug Companies: How they Deceive Us and What to Do about it, Random House: New York, NY, 2004.
2. Eisinger, J. Wall Street Journal, New York, NY, 2004.
3. Amidon, G. L.; Lennernas, H.; Shah, V. P.; Crison, J. R. Pharm. Res., 1995, 12, 413.
4. Kansy, M.; Senner, F.; Gubernator, K. J. Med. Chem., 1998, 41, 1007.
5. Kerns, E. H.; Di, L.; Petusky, S.; Farris, M.; Ley, R.; Jupp, P. J. Pharm. Sci., 2004, 93, 1440.
6. Lennernas, H. J. Pharm. Pharmacol., 1997, 49, 627.
7. Mandagere, A. K.; Thompson, T. N.; Hwang, K. K. J. Med. Chem., 2002, 45, 304.
8. Pade, V.; Stavchansky, S. Pharm. Res., 1997, 14, 1210.
9. Taipalensuu, J.; Tornblom, H.; Lindberg, G.; Einarsson, C.; Sjoqvist, F.; Melhus, H.; Garberg, P.; Sjostrom, B.; Lundgren, B.; Artursson, P. J. Pharmacol. Exp. Ther., 2001, 299, 164.
10. Artursson, P. Crit. Rev. Ther. Drug Carrier Syst., 1991, 8, 305.
11. Augustijns, P. F.; Bradshaw, T. P.; Gan, L. S.; Hendren, R. W.; Thakker, D. R. Biochem. Biophys. Res. Commun., 1993, 197, 360.
12. Gan, L. S.; Moseley, M. A.; Khosla, B.; Augustijns, P. F.; Bradshaw, T. P.; Hendren, R. W.; Thakker, D. R. Drug Metab. Dispos., 1996, 24, 344.
13. Hunter, J.; Hirst, B. H.; Simmons, N. L. Pharm. Res., 1993, 10, 743.
14. Avdeef, A.; Nielsen, P. E.; Tsinman, O. Eur. J. Pharm. Sci., 2004, 22, 365.
15. Sugano, K.; Nabuchi, Y.; Machida, M.; Aso, Y. Int. J. Pharm., 2003, 257, 245.
16. Oh, D. M.; Sinko, P. J.; Amidon, G. L. Int. J. Pharm., 1992, 85, 181.
17. Sutton, S. C.; Rinaldi, M. T.; Vukovinsky, K. E. AAPS PharmSci., 2001, 3, E25.
18. Kulkarni, A.; Han, Y.; Hopfinger, A. J. J Chem. Inf. Comput. Sci., 2002, 42, 331.
19. Ponce, Y. M.; Perez, M. A. C.; Zaldivar, V. R.; Ofori, E.; Montero, L. A. Intern. J. Mol. Sci., 2003, 4, 512.
20. Refsgaard, H. H.; Jensen, B. F.; Brockhoff, P. B.; Padkjaer, S. B.; Guldbrandt, M.; Christensen, M. S. J. Med. Chem., 2005, 48, 805.
21. Komarek, P.; Moore, A. Artificial Intelligence Statistics, 2003.
22. James, C. A.; Weininger, D.; Delany, J. SMARTS, 2004.
23. Troutman, M. D.; Thakker, D. R. Pharm. Res., 2003, 20, 1200.
24. Yamazaki, M.; Neway, W. E.; Ohe, T.; Chen, I.; Rowe, J. F.; Hochman, J. H.; Chiba, M.; Lin, J. H. J. Pharmacol. Exp. Ther., 2001, 296, 723.
25. Schmid, E. F.; Smith, D. A. Drug Discov. Today, 2005, 10, 1031.